April 11th 2025
The spray-dried formulations for Ethris’ mRNA vaccine candidates will be developed at Lonza’s Bend, Ore., Center of Excellence in accordance with GMP standards.
Targeted Delivery of Gene and Cell Therapies
August 1st 2015Gene and cell therapies represent the next-generation treatments for a wide range of diseases, but one challenge in the development of these therapeutics is the controlled delivery to the targeted site to maximize expression or engraftment while limiting systemic exposure.
Innovative Inhaled Antipsychotic Formulation Adasuve Provides Quick and Effective Treatment
May 28th 2015Experts attending the European Psychiatry Association Congress in Vienna say that Adasuve has made an impact in the treatment of agitation in patients suffering from schizophrenia or bipolar I disorder.
AstraZeneca Enters Collaboration with Pharmacyclics and Janssen to Test Hematologic Cancer Treatment
November 4th 2014AstraZeneca announced a partnership with Pharmacyclics and Janssen for combination trials of MEDI4736 (AstraZeneca) with Imbruvica (Pharmacyclics and Janssen) for the treatment of hematologic cancers.